IRF1 and colorectal carcinoma: The hypersensitivity of Irf1−/− mutants to CA-CRC induced by AOM/DSS could result from increased sensitivity to AOM-induced tumorigenesis or, from altered inflammation following exposure to DSS, or the combination of both.